CXCR4 and posterior cortical atrophy: In addition to further supporting a role of CXCR4 in Ac-KLF5-mediated bone lesions, these findings suggest that combined docetaxel and AMD3100 treatment could be an effective therapy for patients with bone metastasis of PCa.